Effects of Lactoferrin on IL-6 Production by Peritoneal and Alveolar Cells in Cyclophosphamide-Treated Mice

REFERENCES

• Lacki JK, Mackiewicz SH, Leszczynski P, Muller W. The effect of intravenous cyclophosphamide pulse on peripheral blood lymphocytes in lupus erythematosus patients. Rheumatol Int 1997; 17: 55–60.
   PubMed Web of Science ®Google Scholar
• Weiner HL, Cohen JA. Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immuno-logic effects. Mult Scler 2002; 8: 142–54.
   PubMed Web of Science ®Google Scholar
• Leandro MJ, Edwards JC, Cambridge G. Clinical out-come in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion. Ann Rheum Dis 2002; 61: 883-8. Comment in: Ann Rheum Dis 2002; 61: 863–6.
   PubMed Web of Science ®Google Scholar
• Asou N, Suzushima H, Hishimura S et al. Long-term remission in an elderly patients with mantle cell leukemia treated with low-dose cyclophosphamide. Am J Haematol 2000; 63: 35–37.
   Google Scholar
• Shalit I, Kletter Y, Halperin D et al. Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia. Eur J Haematol 2001; 66: 287–96.
   Google Scholar
• Hemendinger RA, Bloom SE. Selective mitomycin C and cyclophosphamide induction of apoptosis in differentiating B lymphocytes compared to T lymphocytes in vivo. Immunopharmacology 1996; 35: 71–82.
   PubMed Web of Science ®Google Scholar
• Santosuosso M, Divangahi M, Zganiacz A, Xing Z. Reduced tissue macrophage population in the lung by anti-cancer agent cyclophosphamide: restoration by local granulo-cyte macrophage colony-stimulating factor gene transfer. Blood 2002; 99: 1246–52.
   PubMed Web of Science ®Google Scholar
• Marcinkiewicz J, Bryniarski K, Ptak W. Cyclophosphamide uncovers two separate macrophage sub-populations with opposite immunogenic potential and different patterns of monokine production. Cytokine 1994; 6: 472–77.
   PubMed Web of Science ®Google Scholar
• Karbicka A, Marchlewicz M, Wiszniewska B, Machalinski B. Bone marrow morphology during haematopoietic stem cell mobilisation with cyclophosphamide in mice. Folia Morphol (Warsz) 2003; 62: 435–37.
   PubMedGoogle Scholar
• Buisman AM, Van Zwet TL, Langermans JA, Geertsma MF, Leenen PJ, van Furth R. Different effect of granulocyte colony-stimulating factor or bacterial infection on bone-marrow cells of cyclophosphamide-treated or irradiated mice. Immunology 1999; 97: 601–10.
   PubMed Web of Science ®Google Scholar
• Baveye S, Elass E, Mazurier J, Spik G, Legrand D. Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 1999; 37: 281–6.
   PubMed Web of Science ®Google Scholar
• Gutteberg TJ, Rokke O, Andersen O, Jorgensen T. Early fall of circulating iron and rapid rise of lactoferrin in sep-ticemia and endotoxemia: an early defence mechanism. Scand J Infect Dis 1989; 21: 709–15.
   PubMed Web of Science ®Google Scholar
• Tsuda H, Sekine K, Fujita K, Ligo M. Cancer preven-tion by bovine lactoferrin and underlying mechanisms-a review of experimental and clinical studies. Biochem Cell Biol 2002; 80: 131–6.
   PubMed Web of Science ®Google Scholar
• Mazurier J, Legrand D, Hu WL, Montreuil J, Spik G. Expression of human lactotransferrin receptors in phyto-hemagglutinin-stimulated human peripheral blood lympho-cytes. Isolation of the receptors by antiligand-affinity chro-matography. Eur J Biochem 1989; 179: 481–7.
   Google Scholar
• Miyazawa K, Mantel C, Lu L, Morrison DC, Broxmeyer HE. Lactoferrin-lipopolysaccharide interactions. Effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells. J Immunol 1991; 146: 723–9.
   Google Scholar
• Hu WL, Mazurier J, Montreuil J, Spik G. Isolation and partial characterization of a lactotransferrin receptor from mouse intestinal brush border. Biochemistry 1990; 29: 535–41.
   PubMed Web of Science ®Google Scholar
• Actor JK, Hwang SA, Olsen M, Zimecki M, Hunter RL Jr, Kruzel ML. Lactoferrin immunomodulation of DTH response in mice. Int Immunopharmacol 2002; 2: 475–86.
   PubMed Web of Science ®Google Scholar
• Wlaszczyk A, Zimecki M, Adamik B, Durek G, Kubler A. Immunological status of patients subjected to cardiac surgery: effect of lactoferrin on proliferation and production of interleukin 6 and tumor necrosis factor alpha by peripheral blood mononuclear cells in vitro. Arch Immunol Ther Exp 1997; 45: 201–12.
   PubMedGoogle Scholar
• Kruzel ML, Harari Y, Mailman D, Actor JK, Zimecki M. Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clin Exp Immunol 2002; 130: 25–31.
   PubMed Web of Science ®Google Scholar
• Zimecki M, Mazurier J, Machnicki M, Wieczorek Z, Montreuil J, Spik G. Immunostimulatory activity of lactotrans-ferrin and maturation of CD4- CD8- murine thymocytes. Immunol Lett 1991; 30: 119–23.
   PubMed Web of Science ®Google Scholar
• Zimecki M, Mazurier J, Spik G, Kapp JA. Human lacto-ferrin induces phenotypic and functional changes in murine splenic B cells. Immunology 1995; 86: 122–7.
   PubMed Web of Science ®Google Scholar
• Bagay GC Jr, McCall E, Layman DL. Regulation of colony-stimulating activity production. Interactions of fibrob-lasts, mononuclear phagocytes, and lactoferrin. J Clin Invest 1983; 71: 340–4.
   Google Scholar
• Rich IN, Sawatzki G. Lactoferrin, the signal for colony stimulating factor production? Negative-feedback regulation versus supply-and-demand regulation of myelopoiesis. Blood Cells 1989; 15: 400–6.
   PubMedGoogle Scholar
• Artym J, Zimecki M, Kruzel ML. Reconstitution of the cellular immune response by lactoferrin in cyclophosphamide-treated mice is correlated with renewal of T cell compartment. Immunobiology 2003; 207: 197–205.
   PubMed Web of Science ®Google Scholar
• Artym J, Zimecki M, Paprocka M, Kruzel ML. Orally administered lactoferrin restores humoral immune response in immunocompromised mice. Immunol Lett 2003; 89: 9–15.
   PubMed Web of Science ®Google Scholar
• Artym J, Zimecki M, Kruzel ML. Normalization of peripheral blood cell composition in cyclophosphamide treated mice by lactoferrin. Med Sci Monit 2004; 10 (3): BR 84-89.
   Google Scholar
• Tritarelli E, Greco G, Testa U, Belardelli F, Peschle C, Proietti E. Combined interleukin-1 beta/interleukin-6 treat-ment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelo-suppression. Cancer Res 1994; 54: 6469-76.
   Google Scholar
• D'Hondt V, Humblet Y, Guillaume T et al. Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multi-centric placebo-controlled, randomized phase lb study. Blood 1995; 85: 2347–53.
   Google Scholar
• Bryniarski K, Ptak M, Ptak W. The in vivo and in vitro effects of an alkylating agent, mechlorethamine, on IL-6 pro-duction in mice and the role of macrophages. Immunopharmacology 1996; 34: 73–8.
   PubMed Web of Science ®Google Scholar
• Kalechman Y, Rushkin G, Nerubay J, Albeck M, Sredni B. Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice. Exp Hematol 1995; 23: 1358-66.
   Google Scholar
• Steinshamn S, Waage A. Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and gran-ulocytopenic mice. Infect Immun 1992; 60: 4003–8.
   PubMed Web of Science ®Google Scholar
• Van Snick J, Cayphas S, Vink A et al. Purification and NH2-terminal amino acid sequence of a T-cell-derived lym-phokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci U S A 1986; 83: 9679–83.
   Google Scholar
• Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989; 119: 203–10.
   PubMed Web of Science ®Google Scholar
• Shalit I, Horev-Azaria L, Fabian I, et al. Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced brochopneumonia in mice injected with cyclophosphamide. Antimicrob Chemother 2002; 46: 242–2449.
   PubMed Web of Science ®Google Scholar
• McIntyre KW, Unowsky J, DeLorenzo W, Benjamin W. Enhancement of antibacterial resistance of neutropenic, bone marrow-suppressed mice by interleukin-1 alpha. Infect Immun 1989; 57: 48–54.
   PubMed Web of Science ®Google Scholar
• Wang E, Simard M, Ouellet N, Bergeron Y, Beauchamp D, Bergeron MG. Pathogenesis of pneumococcal pneumonia in cyclophosphamide-induced leukopenia in mice. Infect Immun 2002; 70: 4226–38.
   PubMed Web of Science ®Google Scholar
• Dalrymple SA, Slattery R, Aud DM, Krishna M, Lucian LA, Murray R. Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect Immun 1996; 64: 3231–5.
   PubMed Web of Science ®Google Scholar
• Mianji S, Hamasaki Y, Yamamoto S, Miyazaki S. Inhibition by dexamethasone of the lipopolysaccharide-induced increase in IL-6 mRNA abundance and IL-6 production in human polymorphonuclear leukocytes. Int J Immunopharmacol 1996; 18: 339–46.
   PubMed Web of Science ®Google Scholar
• Conti P, Kempuraj D, Di Gioacchino M et al. Interleukin-6 and mast cells. Allergy Asthma Proc 2002; 23: 331–5.
   PubMed Web of Science ®Google Scholar
• Krasnozhenov EP. Morphofunctional status of tissue basophils in cytostatic disease. Patol Fiziol Eksp Ter 1994; 1: 12–3.
   PubMedGoogle Scholar
• Malaviya R, Georges A. Regulation of mast cell-mediat-ed innate immunity during early response to bacterial infec-tion. Clin Rev Allergy Immunol 2002; 22: 189–204.
   PubMed Web of Science ®Google Scholar
• Zimecki M, Kruzel M. Protective effect of lactoferrin against LPS-induced endotoxemia is mediated by IL-10. Proceedings of the 5th World Congress on Trauma, Shock, Inflammation and Sepsis, 2000 Feb 29 - Mar 4; Munich, Germany. Monduzzi Editore; 2000.
   Google Scholar